Found: 53
Select item for more details and to access through your institution.
Effects of COVID-19 Vaccination Timing and Risk Prioritization on Mortality Rates, United States.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Structural basis for antibody recognition of vulnerable epitopes on Nipah virus F protein.
- Published in:
- Nature Communications, 2023, v. 14, p. 1, doi. 10.1038/s41467-023-36995-y
- By:
- Publication type:
- Article
Chimeric <italic>Pneumoviridae</italic> fusion proteins as immunogens to induce cross‐neutralizing antibody responses.
- Published in:
- EMBO Molecular Medicine, 2018, v. 10, n. 2, p. 175, doi. 10.15252/emmm.201708078
- By:
- Publication type:
- Article
Iterative screen optimization maximizes the efficiency of macromolecular crystallization.
- Published in:
- Acta Crystallographica: Section F, Structural Biology Communications, 2019, v. 75, n. 2, p. 123, doi. 10.1107/S2053230X18017338
- By:
- Publication type:
- Article
Structure-based design of prefusion-stabilized human metapneumovirus fusion proteins.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-28931-3
- By:
- Publication type:
- Article
Author Correction: Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Efficient discovery of SARS-CoV-2-neutralizing antibodies via B cell receptor sequencing and ligand blocking.
- Published in:
- Nature Biotechnology, 2022, v. 40, n. 8, p. 1270, doi. 10.1038/s41587-022-01232-2
- By:
- Publication type:
- Article
Structural basis for diverse N-glycan recognition by HIV-1-neutralizing V1-V2-directed antibody PG16.
- Published in:
- Nature Structural & Molecular Biology, 2013, v. 20, n. 7, p. 804, doi. 10.1038/nsmb.2600
- By:
- Publication type:
- Article
Structural basis of respiratory syncytial virus neutralization by motavizumab.
- Published in:
- Nature Structural & Molecular Biology, 2010, v. 17, n. 2, p. 248, doi. 10.1038/nsmb.1723
- By:
- Publication type:
- Article
Prefusion-stabilized SARS-CoV-2 S2-only antigen provides protection against SARS-CoV-2 challenge.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-45404-x
- By:
- Publication type:
- Article
Engineered dityrosine-bonding of the RSV prefusion F protein imparts stability and potency advantages.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-46295-8
- By:
- Publication type:
- Article
Nanoparticle display of prefusion coronavirus spike elicits S1-focused cross-reactive antibody response against diverse coronavirus subgenera.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-41661-4
- By:
- Publication type:
- Article
A Cysteine Zipper Stabilizes a Pre-Fusion F Glycoprotein Vaccine for Respiratory Syncytial Virus.
- Published in:
- PLoS ONE, 2015, v. 10, n. 6, p. 1, doi. 10.1371/journal.pone.0128779
- By:
- Publication type:
- Article
N332-Directed Broadly Neutralizing Antibodies Use Diverse Modes of HIV-1 Recognition: Inferences from Heavy-Light Chain Complementation of Function.
- Published in:
- PLoS ONE, 2013, v. 8, n. 2, p. 1, doi. 10.1371/journal.pone.0055701
- By:
- Publication type:
- Article
Structure and mechanism of the farnesyl diphosphate synthase from Trypanosoma cruzi: Implications for drug design.
- Published in:
- Proteins, 2006, v. 62, n. 1, p. 80, doi. 10.1002/prot.20754
- By:
- Publication type:
- Article
Structural basis for antibody binding to adenylate cyclase toxin reveals RTX linkers as neutralization-sensitive epitopes.
- Published in:
- PLoS Pathogens, 2021, v. 17, n. 9, p. 1, doi. 10.1371/journal.ppat.1009920
- By:
- Publication type:
- Article
Structure-Based Design of Nipah Virus Vaccines: A Generalizable Approach to Paramyxovirus Immunogen Development.
- Published in:
- Frontiers in Immunology, 2020, p. 1, doi. 10.3389/fimmu.2020.00842
- By:
- Publication type:
- Article
Transient opening of trimeric prefusion RSV F proteins.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-09807-5
- By:
- Publication type:
- Article
Alternative conformations of a major antigenic site on RSV F.
- Published in:
- PLoS Pathogens, 2019, v. 15, n. 7, p. 1, doi. 10.1371/journal.ppat.1007944
- By:
- Publication type:
- Article
Structural basis for recognition of the central conserved region of RSV G by neutralizing human antibodies.
- Published in:
- PLoS Pathogens, 2018, v. 14, n. 3, p. 1, doi. 10.1371/journal.ppat.1006935
- By:
- Publication type:
- Article
The mode of Hedgehog binding to Ihog homologues is not conserved across different phyla.
- Published in:
- Nature, 2008, v. 455, n. 7215, p. 979, doi. 10.1038/nature07358
- By:
- Publication type:
- Article
Characterization of a human monoclonal antibody generated from a B-cell specific for a prefusion-stabilized spike protein of Middle East respiratory syndrome coronavirus.
- Published in:
- PLoS ONE, 2020, v. 15, n. 5, p. 1, doi. 10.1371/journal.pone.0232757
- By:
- Publication type:
- Article
Prolonged evolution of the human B cell response to SARS-CoV-2 infection.
- Published in:
- Science Immunology, 2021, v. 6, n. 56, p. 1, doi. 10.1126/sciimmunol.abg6916
- By:
- Publication type:
- Article
Rapid profiling of RSV antibody repertoires from the memory B cells of naturally infected adult donors.
- Published in:
- Science Immunology, 2016, v. 1, n. 6, p. 1, doi. 10.1126/sciimmunol.aaj1879
- By:
- Publication type:
- Article
Trimeric SARS-CoV-2 Spike Proteins Produced from CHO Cells in Bioreactors Are High-Quality Antigens.
- Published in:
- Processes, 2020, v. 8, n. 12, p. 1539, doi. 10.3390/pr8121539
- By:
- Publication type:
- Article
Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state.
- Published in:
- Nature Communications, 2017, v. 8, n. 2, p. 14158, doi. 10.1038/ncomms14158
- By:
- Publication type:
- Article
A highly stable prefusion RSV F vaccine derived from structural analysis of the fusion mechanism.
- Published in:
- Nature Communications, 2015, v. 6, n. 9, p. 8143, doi. 10.1038/ncomms9143
- By:
- Publication type:
- Article
A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants.
- Published in:
- Science Translational Medicine, 2017, v. 9, n. 388, p. 1, doi. 10.1126/scitranslmed.aaj1928
- By:
- Publication type:
- Article
Suptavumab for the Prevention of Medically Attended Respiratory Syncytial Virus Infection in Preterm Infants.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 11, p. e4400, doi. 10.1093/cid/ciaa951
- By:
- Publication type:
- Article
Characterization of a Prefusion-Specific Antibody That Recognizes a Quaternary, Cleavage-Dependent Epitope on the RSV Fusion Glycoprotein.
- Published in:
- PLoS Pathogens, 2015, v. 11, n. 7, p. 1, doi. 10.1371/journal.ppat.1005035
- By:
- Publication type:
- Article
Infection with MERS-CoV Causes Lethal Pneumonia in the Common Marmoset.
- Published in:
- PLoS Pathogens, 2014, v. 10, n. 8, p. 1, doi. 10.1371/journal.ppat.1004250
- By:
- Publication type:
- Article
A novel humanized Chi3l1 blocking antibody attenuates acetaminophen-induced liver injury in mice.
- Published in:
- Antibody Therapeutics, 2023, v. 6, n. 1, p. 1, doi. 10.1093/abt/tbac027
- By:
- Publication type:
- Article
Engineering, Structure and Immunogenicity of the Human Metapneumovirus F Protein in the Postfusion Conformation.
- Published in:
- PLoS Pathogens, 2016, v. 12, n. 9, p. 1, doi. 10.1371/journal.ppat.1005859
- By:
- Publication type:
- Article
Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9.
- Published in:
- Nature, 2011, v. 480, n. 7377, p. 336, doi. 10.1038/nature10696
- By:
- Publication type:
- Article
Structural basis of respiratory syncytial virus subtype-dependent neutralization by an antibody targeting the fusion glycoprotein.
- Published in:
- Nature Communications, 2017, v. 8, n. 1, p. 1, doi. 10.1038/s41467-017-01858-w
- By:
- Publication type:
- Article
Structure and immunogenicity of pre-fusion-stabilized human metapneumovirus F glycoprotein.
- Published in:
- Nature Communications, 2017, v. 8, n. 1, p. 1, doi. 10.1038/s41467-017-01708-9
- By:
- Publication type:
- Article
Corrigendum: Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state.
- Published in:
- Nature Communications, 2017, v. 8, n. 11, p. 16165, doi. 10.1038/ncomms16165
- By:
- Publication type:
- Article
Publisher Correction: Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-34171-7
- By:
- Publication type:
- Article
Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-34171-7
- By:
- Publication type:
- Article
Simulation-driven design of stabilized SARS-CoV-2 spike S2 immunogens.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-50976-9
- By:
- Publication type:
- Article
Structural basis for potent neutralization of human respirovirus type 3 by protective single-domain camelid antibodies.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-49757-1
- By:
- Publication type:
- Article
Universal paramyxovirus vaccine design by stabilizing regions involved in structural transformation of the fusion protein.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-48059-w
- By:
- Publication type:
- Article
A MERS-CoV antibody neutralizes a pre-emerging group 2c bat coronavirus.
- Published in:
- Science Translational Medicine, 2023, v. 15, n. 715, p. 1, doi. 10.1126/scitranslmed.adg5567
- By:
- Publication type:
- Article
Elicitation of pneumovirus-specific B cell responses by a prefusion-stabilized respiratory syncytial virus F subunit vaccine.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 650, p. 1, doi. 10.1126/scitranslmed.abo5032
- By:
- Publication type:
- Article
Expression and characterization of SARS-CoV-2 spike proteins.
- Published in:
- Nature Protocols, 2021, v. 16, n. 11, p. 5339, doi. 10.1038/s41596-021-00623-0
- By:
- Publication type:
- Article
Global site-specific analysis of glycoprotein N-glycan processing.
- Published in:
- Nature Protocols, 2018, v. 13, n. 6, p. 1196, doi. 10.1038/nprot.2018.024
- By:
- Publication type:
- Article
Synthetic glycopeptides reveal the glycan specificity of HIV-neutralizing antibodies.
- Published in:
- Nature Chemical Biology, 2013, v. 9, n. 8, p. 521, doi. 10.1038/nchembio.1288
- By:
- Publication type:
- Article
Recognition of a highly conserved glycoprotein B epitope by a bivalent antibody neutralizing HCMV at a post-attachment step.
- Published in:
- PLoS Pathogens, 2020, v. 16, n. 8, p. 1, doi. 10.1371/journal.ppat.1008736
- By:
- Publication type:
- Article
Local computational methods to improve the interpretability and analysis of cryo-EM maps.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-21509-5
- By:
- Publication type:
- Article
Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-020-20789-7
- By:
- Publication type:
- Article